Early experience with the Drivewire 24: a newly FDA-approved steerable microwire
The DW24 demonstrated a high technical success rate with no device-related complications. Its versatility across catheter sizes and precise controllability facilitate navigating complex cerebrovasculature. Further studies should assess efficacy in larger cohorts across additional clinical scenarios.
Authors
- Eytan Raz (ORCID: https://orcid.org/0000-0003-2998-8481)
- Maksim Shapiro (ORCID: https://orcid.org/0000-0003-1279-5456)
- Charlotte Y. Chung (ORCID: https://orcid.org/0000-0003-0671-4111)
- Howard A. Riina (ORCID: https://orcid.org/0000-0002-9303-8176)
- Jacob F. Baranoski (ORCID: https://orcid.org/0000-0001-8361-9383)
- Vera Sharashidze (ORCID: https://orcid.org/0000-0002-9315-7108)
- Erez Nossek
- Caleb Rutledge (ORCID: https://orcid.org/0000-0002-0485-3065)
- Eric A. Grin (ORCID: https://orcid.org/0009-0005-0369-9704)
Institutions
- New York University (US)
Publication Details
- Journal
- Journal of NeuroInterventional Surgery
- Published
- 2025-06-20
- DOI
- https://doi.org/10.1136/jnis-2025-023730
- Citations
- 3
- Primary Topic
- Vascular Malformations Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.17